Medirom Healthcare Technologies Stock Alpha and Beta Analysis
| MRM Stock | USD 1.83 0.09 4.69% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Medirom Healthcare Technologies. It also helps investors analyze the systematic and unsystematic risks associated with investing in Medirom Healthcare over a specified time horizon. Remember, high Medirom Healthcare's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Medirom Healthcare's market risk premium analysis include:
Beta 0.22 | Alpha (0.06) | Risk 4.55 | Sharpe Ratio (0.03) | Expected Return (0.12) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out Medirom Healthcare Backtesting, Medirom Healthcare Valuation, Medirom Healthcare Correlation, Medirom Healthcare Hype Analysis, Medirom Healthcare Volatility, Medirom Healthcare History and analyze Medirom Healthcare Performance. Medirom Healthcare Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Medirom Healthcare market risk premium is the additional return an investor will receive from holding Medirom Healthcare long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Medirom Healthcare. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Medirom Healthcare's performance over market.| α | -0.06 | β | 0.22 |
Medirom Healthcare expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Medirom Healthcare's Buy-and-hold return. Our buy-and-hold chart shows how Medirom Healthcare performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Medirom Healthcare Market Price Analysis
Market price analysis indicators help investors to evaluate how Medirom Healthcare stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Medirom Healthcare shares will generate the highest return on investment. By understating and applying Medirom Healthcare stock market price indicators, traders can identify Medirom Healthcare position entry and exit signals to maximize returns.
| Price Series Summation | ||
| Price Series Division | ||
| Inverse Tangent Over Price Movement | ||
| Price Ceiling Movement | ||
| Aroon Oscillator | ||
| Balance Of Power | ||
| Parabolic SAR | ||
| MidPoint over period | ||
| Stalled Pattern | ||
| Separating Lines |
Medirom Healthcare Return and Market Media
The median price of Medirom Healthcare for the period between Thu, Oct 9, 2025 and Wed, Jan 7, 2026 is 2.08 with a coefficient of variation of 9.23. The daily time series for the period is distributed with a sample standard deviation of 0.2, arithmetic mean of 2.13, and mean deviation of 0.14. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | How Did MEDIROM Healthcare Technologies Inc.s 14 percent ROE Fare Against The Industry | 10/14/2025 |
2 | MEDIROM Healthcare Technologies Reports September 2025 KPIs and Expands Health Tech Reach - TipRanks | 10/20/2025 |
3 | MEDIROM to Launch New Treasury Strategy Utilizing Cryptocurrency | 10/29/2025 |
4 | MEDIROM Healthcare Technologies Reports Strong October 2025 KPIs - TipRanks | 12/03/2025 |
5 | Medirom Healthcare Technologies issues convertible bonds to boost financial flexibility - MSN | 12/11/2025 |
6 | MEDIROM Healthcare Technologies Completes JPY400 Million Bond Issuance - The Globe and Mail | 12/16/2025 |
7 | MEDIROM Partners with World | 12/26/2025 |
8 | Disposition of 17000 shares by Cohen Edward H of Medirom Healthcare at 16.0 subject to Rule 16b-3 | 12/31/2025 |
About Medirom Healthcare Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Medirom or other stocks. Alpha measures the amount that position in Medirom Healthcare has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2023 | 2024 | 2025 | 2026 (projected) | Payables Turnover | 38.19 | 5.97 | 6.86 | 6.52 | Days Of Inventory On Hand | 9.72 | 9.14 | 8.23 | 8.64 |
Medirom Healthcare Upcoming Company Events
As portrayed in its financial statements, the presentation of Medirom Healthcare's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Medirom Healthcare's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Medirom Healthcare's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Medirom Healthcare. Please utilize our Beneish M Score to check the likelihood of Medirom Healthcare's management manipulating its earnings.
| 29th of May 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Build Portfolio with Medirom Healthcare
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Medirom Healthcare Backtesting, Medirom Healthcare Valuation, Medirom Healthcare Correlation, Medirom Healthcare Hype Analysis, Medirom Healthcare Volatility, Medirom Healthcare History and analyze Medirom Healthcare Performance. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Medirom Healthcare technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.